DDrare: Database of Drug Development for Rare Diseases

Searched query = "Interstitial cystitis with Hunners ulcer", "Interstitial cystitis"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

Drug = 2% sodium chondroitin sulfate; 5% lidocaine/5 mg/ml 0.02% estradiol compound cream; AGN 203818; AQX-1125; AQX-1125 100 mg; AQX-1125 200 mg; ASP3652; ASP6294; Adalimumab; Alkalinized Lidocaine-Heparin; Amitriptyline; BOTOX 200U in normal saline; Bladder Instillations; Bladder instillation WITH triamcinolone acetonide; Bladder instillation WITHOUT triamcinolone acetonide; Bladder instillation with heparin/ lidocaine; Botox; Botulinum toxin A; Buckwheat; Bupivacaine; CICLOSPORIN; Cannabidiol; Cannabidiol vaginal suppository; Capsaicin; Certolizumab pegol; Chondroitin sulfate; Ciclosporin; Ciklosporin; Combination Product: Hyperbaric Oxygen Therapy-; Cyclosporine; DMSO; DMSO cocktail; Device: Intermittent Exposure to Oxygen via Oro-Nasal Mask; Device: interferential current; Dexmedetomidine; Dimethyl sulfoxide; ERB-041; Estradiol; Fospropofol; Fospropofol (Lusedra®) 10; Fospropofol (Lusedra®) 12; Fospropofol (Lusedra®) 6.5; Fremanezumab; Gefapixant; Glycine; Gralise; Heparin; Heparin & Alkalinized Lidocaine Bladder Instillation; Hyaluronic Acid and Chondroitin Sulfate; Hyaluronic acid; Hyaluronic acid/chondroitin sulfate; Hydrogen; IC Cocktail; IPD® (Japanese tradename); IPD® (suplatast tosilate); Intravesical onabotulinumtoxinA injection; JNJ-42160443; KRP-116D; Ketorolac; Ketorolac Tromethamine; LP-08 20mg; LP-08 80mg; LiRIS 400 mg; LiRIS low dose and LiRIS high dose; LiRIS®; LiRIS® 400 mg; Lidocaine; Lidocaine Releasing Intravesical System - LiRIS®; Liposome encapsulated BoNT-A; Liposomes; Low-dose naltrexone; MMF; MN-001; MN-001 BID; MR-MC-01; Metoprolol; Metoprolol Tartrate Oral Tablet; Mirabegron; Mycofenolate Mofetil (MMF); Mycophenolate; Mycophenolate Mofetil; Mycophenolate mofetil; NALOXONE HYDROCHLORIDE; Naloxone; Naltrexone; Normal Saline; Normal saline; Normal saline instillation; Nortriptyline; OXN 10/5 mg PR; OXN 20/10 mg PR; OXN 5/2.5 mg PR; OXYCODONE HYDROCHLORIDE; Omalizumab; Onabotulinum Toxin A; Onabotulinumtoxin A; OnabotulinumtoxinA; Other: Hyperbaric Oxygen Therapy; Other: Normal Saline; Other: Saline as a nasal spray; Other: inactive drug; Other: normal saline; Oxycodone; Oxycodone naloxone prolonged release tablets; Oxycodone/naloxone prolonged release t; Oxycodone/naloxone prolonged release tablets 10/5 mg; Oxycodone/naloxone prolonged release tablets 20/10 mg; Oxycodone/naloxone prolonged release tablets 5/2.5 mg; Oxygen; Oxytocin; PD 0299685; PD 0299685 at 15mg BID; PD 0299685 at 30mg BID; PD-0299685; PF-04383119; Pentosan polysulfate; Pentosan polysulfate sodium 100 mg; Placebo; Platelet enriched plasma; Platelet-Rich Plasma; Procedure: Pelvic Floor Physical Therapy; Procedure: Sham Cystoscopy Procedure; Procedure: Urodynamic study; Procedure: injections on posterior bladder wall excluding the trigone; Procedure: injections upper aspect of trigone of urinary bladder; Prograf; Propiverine; Propiverine Hydrochloride; RIMSO 50; RN624, RI624; Rimso 50; SANDIMMUN; SI-722; Sandimmun Neoral; Sildenafil; Sulfate; Suplatast tosilate; TACROLIMUS; TTI-1612; Tacrolimus; Tanezumab; Targinact 10 mg/5 mg prolonged-release tablets; Targinact 20mg/10 mg prolonged-release tablets; Targinact 5mg/2.5 mg prolonged-release tablets; Tramadol; Triamcinolone; Tromethamine; URG101; Water; YM672; YM672 (IPD®)

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	JPRN-UMIN000014860	2014/10/31	01/09/2014	Efficacy and safety of intravesical administration of dimethyl sulfoxide (DMSO) in interstitial patients	Efficacy and safety of intravesical administration of dimethyl sulfoxide (DMSO) in interstitial patients - Efficacy and safety of intravesical administration of dimethyl sulfoxide (DMSO) in interstitial patients	interstitial cystitis	intravesical administration of DMSO	Urology, Hokkaido University Graduate School of Medicine	NULL	Complete: follow-up complete	20years-old	Not applicable	Male and Female	10	Not selected	Japan
2	EUCTR2010-021556-25-IT (EUCTR)	24/02/2011	04/11/2010	Phase III, randomized, open-label, multicenter evaluation of efficacy and tolerability `of Ialuril (sodium hyaluronate-chondroitin sulfate) vs. dimethyl sulfoxide (DMSO) in women with interstitial cystitis / painful bladder syndrome (IC / BPS)AscoltaTrascrizione foneticaDizionario - Visualizza dizionario dettagliato - IBSA 01-2010	Phase III, randomized, open-label, multicenter evaluation of efficacy and tolerability `of Ialuril (sodium hyaluronate-chondroitin sulfate) vs. dimethyl sulfoxide (DMSO) in women with interstitial cystitis / painful bladder syndrome (IC / BPS)AscoltaTrascrizione foneticaDizionario - Visualizza dizionario dettagliato - IBSA 01-2010	Interstitial Cystitis MedDRA version: 9.1;Level: HLGT;Classification code 10018188	Trade Name: RIMSO 50 INN or Proposed INN: Dimethyl sulfoxide	IBSA	NULL	Not Recruiting			Female: yes Male: no		Phase 3	Italy
3	NCT01069263 (ClinicalTrials.gov)	February 2010	10/1/2010	Comparative Study Between Hyperbaric Therapy and Intravesical Dimethyl Sulfoxide Instillation for Interstitial Cystitis	Comparison Between Hyperbaric Oxygen Therapy (HBOT) and Intravesical Dimethyl Sulfoxide (DMSO) Instillation for the Treatment of Interstitial Cystitis - a Prospective, Randomized Cross-over Trial	Interstitial Cystitis	Other: Hyperbaric Oxygen Therapy;Drug: DMSO	Assaf-Harofeh Medical Center	NULL	Recruiting	18 Years	85 Years	Both	60	N/A	Israel
4	NCT01074567 (ClinicalTrials.gov)	December 2009	23/2/2010	DMSO Efficacy in IC/PBS Patients During and After Treatment	Efficacy of DMSO Cocktail Treatment in Interstitial Cystitis Patients During and After Treatment	Cystitis, Interstitial	Drug: DMSO cocktail	Assaf-Harofeh Medical Center	NULL	Recruiting	18 Years	N/A	Female	50	N/A	Israel
5	NCT00317070 (ClinicalTrials.gov)	April 2006	20/4/2006	Trial Comparing Intravesical Cocktail With Intravesical Dimethyl Sulfoxide (DMSO) in Painful Bladder Syndrome/Interstitial Cystitis (PBS/IC)	A Randomized Controlled Trial to Evaluate the Efficacy and Tolerability of Intravesical Cocktail and Comparison With Intravesical Dimethyl Sulfoxide (DMSO) for the Treatment of Painful Bladder Syndrome Including Interstitial Cystitis (PBS/IC)	Interstitial Cystitis;Bladder Diseases	Drug: dimethyl sulfoxide;Drug: IC Cocktail	Capital District Health Authority, Canada	NULL	Terminated	18 Years	N/A	Both	10	Phase 2	Canada
No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
6	JPRN-UMIN000003172	2005/05/01	12/02/2010	Clinacal study on the intravesical instillation of dimethylsulfoxide (DMSO) for the patients with interstitial cystitis		Interstitial cystitis	Intravesical instillation of DMSO	Deparment of Urology, Medical Science, University of Fukui	NULL	Recruiting	Not applicable	Not applicable	Male and Female	30	Not applicable	Japan
7	JPRN-UMIN000027494	2004/07/20	25/05/2017	Intravesical administration of Dimethyl sulfoxide(DMSO) for patients with Interstitial cystitis	Intravesical administration of Dimethyl sulfoxide(DMSO) for patients with Interstitial cystitis - Dimethyl sulfoxide(DMSO) for patients with Interstitial cystitis	Interstitial cystitis	Intravesical DMSO administration (50%, 50ml),2weeks every, 8 times	Department of Urology, Hamamatsu University School of Medicine	NULL	Complete: follow-up complete	20years-old	Not applicable	Male and Female	20	Not applicable	Japan

No.

TrialID

Date_
enrollment

Date_
registration

Public_title

Scientific_title

Condition

Intervention

Primary_
sponsor

Secondary_
sponsor

Recruitment_
Status

Inclusion_
agemin

Inclusion_
agemax

Inclusion_
gender

Target_
size

Phase

Countries

JPRN-UMIN000014860

2014/10/31

01/09/2014

Efficacy and safety of intravesical administration of dimethyl sulfoxide (DMSO) in interstitial patients

Efficacy and safety of intravesical administration of dimethyl sulfoxide (DMSO) in interstitial patients - Efficacy and safety of intravesical administration of dimethyl sulfoxide (DMSO) in interstitial patients

interstitial cystitis

intravesical administration of DMSO

Urology, Hokkaido University Graduate School of Medicine

NULL

Complete: follow-up complete

20years-old

Not applicable

Male and Female

Not selected

Japan

EUCTR2010-021556-25-IT
(EUCTR)

24/02/2011

04/11/2010

Phase III, randomized, open-label, multicenter evaluation of efficacy and tolerability `of Ialuril (sodium hyaluronate-chondroitin sulfate) vs. dimethyl sulfoxide (DMSO) in women with interstitial cystitis / painful bladder syndrome (IC / BPS)AscoltaTrascrizione foneticaDizionario - Visualizza dizionario dettagliato - IBSA 01-2010

Interstitial Cystitis
MedDRA version: 9.1;Level: HLGT;Classification code 10018188

Trade Name: RIMSO 50
INN or Proposed INN: Dimethyl sulfoxide

IBSA

NULL

Not Recruiting

Female: yes
Male: no

Phase 3

Italy

NCT01069263
(ClinicalTrials.gov)

February 2010

10/1/2010

Comparative Study Between Hyperbaric Therapy and Intravesical Dimethyl Sulfoxide Instillation for Interstitial Cystitis

Comparison Between Hyperbaric Oxygen Therapy (HBOT) and Intravesical Dimethyl Sulfoxide (DMSO) Instillation for the Treatment of Interstitial Cystitis - a Prospective, Randomized Cross-over Trial

Interstitial Cystitis

Other: Hyperbaric Oxygen Therapy;Drug: DMSO

Assaf-Harofeh Medical Center

NULL

Recruiting

18 Years

85 Years

Both

N/A

Israel

NCT01074567
(ClinicalTrials.gov)

December 2009

23/2/2010

DMSO Efficacy in IC/PBS Patients During and After Treatment

Efficacy of DMSO Cocktail Treatment in Interstitial Cystitis Patients During and After Treatment

Cystitis, Interstitial

Drug: DMSO cocktail

Assaf-Harofeh Medical Center

NULL

Recruiting

18 Years

N/A

Female

N/A

Israel

NCT00317070
(ClinicalTrials.gov)

April 2006

20/4/2006

Trial Comparing Intravesical Cocktail With Intravesical Dimethyl Sulfoxide (DMSO) in Painful Bladder Syndrome/Interstitial Cystitis (PBS/IC)

A Randomized Controlled Trial to Evaluate the Efficacy and Tolerability of Intravesical Cocktail and Comparison With Intravesical Dimethyl Sulfoxide (DMSO) for the Treatment of Painful Bladder Syndrome Including Interstitial Cystitis (PBS/IC)

Interstitial Cystitis;Bladder Diseases

Drug: dimethyl sulfoxide;Drug: IC Cocktail

Capital District Health Authority, Canada

NULL

Terminated

18 Years

N/A

Both

Phase 2

Canada

No.

TrialID

Date_
enrollment

Date_
registration

Public_title

Scientific_title

Condition

Intervention

Primary_
sponsor

Secondary_
sponsor

Recruitment_
Status

Inclusion_
agemin

Inclusion_
agemax

Inclusion_
gender

Target_
size

Phase

Countries

JPRN-UMIN000003172

2005/05/01

12/02/2010

Clinacal study on the intravesical instillation of dimethylsulfoxide (DMSO) for the patients with interstitial cystitis

Interstitial cystitis

Intravesical instillation of DMSO

Deparment of Urology, Medical Science, University of Fukui

NULL

Recruiting

Not applicable

Male and Female

Not applicable

Japan

JPRN-UMIN000027494

2004/07/20

25/05/2017

Intravesical administration of Dimethyl sulfoxide(DMSO) for patients with Interstitial cystitis

Intravesical administration of Dimethyl sulfoxide(DMSO) for patients with Interstitial cystitis - Dimethyl sulfoxide(DMSO) for patients with Interstitial cystitis

Interstitial cystitis

Intravesical DMSO administration (50%, 50ml),2weeks every, 8 times

Department of Urology, Hamamatsu University School of Medicine

NULL

Complete: follow-up complete

20years-old

Not applicable

Male and Female

Not applicable

Japan